Latest Triple Combination of Empagliflozin, Sitagliptin and Metformin for Advanced Care in Indian T2DM Patients - When to Consider?
In this episode of The Diabetes Wellness Forum, titled "Managing Uncontrolled T2D-Applying Advanced Treatment Options," Dr Nandita Mohan from Medical Dialogues is in conversation with Dr Vaishali Deshmukh, Consultant Diabetologist & Endocrinologist at Deenanath Mangeshkar Hospital, Pune, Maharashtra and Dr Altamash Shaikh, Consultant Endocrinologist & Diabetologist and Metabolic Physician, Saifee Hospital, Mumbai, Maharashtra, to discuss a critical aspect of diabetes care in 2025.
With Type 2 diabetes increasingly affecting younger individuals in India and showing rapid disease progression, early and effective glucose control has become essential to prevent long-term microvascular and macrovascular complications. It highlights real-world strategies and contemporary approaches to early aggressive glucose management in 2025.
During this episode, the experts address three key clinical questions:
1. What is the burden of uncontrolled Type 2 diabetes and the major clinical challenges in managing these patients?
2. What is the clinical utility of the empagliflozin, sitagliptin, and metformin combination in uncontrolled Type 2 diabetes?
3. Which patient profiles are best suited for empagliflozin, sitagliptin, and metformin fixed-dose combination therapy?
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.